• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 3. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 4. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
• 5. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Primary alcohols
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alcohols and polyols Primary alcohols

Chemical Profile of Spiro[3.3]heptan-2-ylmethanol (CAS No. 4483-67-4)

Spiro[3.3]heptan-2-ylmethanol, identified by the Chemical Abstracts Service Number (CAS No.) 4483-67-4, is a compound of significant interest in the field of organic chemistry and pharmaceutical research. This spirocyclic alcohol belongs to a class of molecules characterized by a unique structural framework, which has garnered attention due to its potential applications in drug discovery and material science. The spirocyclic core, consisting of two fused rings connected by a single carbon atom, imparts distinct stereochemical and electronic properties that make this molecule a valuable scaffold for medicinal chemistry.

The molecular structure of Spiro[3.3]heptan-2-ylmethanol features a seven-membered spirocycle with an alcohol functional group at the 2-position and a methyl group at the 5-position. This configuration creates a rigid yet flexible framework, allowing for diverse functionalization and interaction with biological targets. The compound’s stereochemistry, particularly the relative configuration of the substituents around the spiro carbon, plays a crucial role in its biological activity and pharmacokinetic properties.

In recent years, there has been growing interest in spirocyclic compounds due to their ability to exhibit potent binding interactions with biological macromolecules. The unique conformational rigidity provided by the spiro linkage can enhance binding affinity and selectivity, making such compounds attractive candidates for drug development. Spiro[3.3]heptan-2-ylmethanol has been explored as a building block in the synthesis of more complex molecules designed to modulate specific biological pathways.

One of the most compelling aspects of Spiro[3.3]heptan-2-ylmethanol is its versatility in synthetic chemistry. The presence of both an alcohol and a methyl group provides multiple sites for chemical modification, enabling the creation of derivatives with tailored properties. For instance, the alcohol moiety can be used to form esters, ethers, or conjugates with other biomolecules, while the methyl group can serve as a point of attachment for pharmacophores or other functional groups. These attributes make Spiro[3.3]heptan-2-ylmethanol a valuable intermediate in the synthesis of novel therapeutic agents.

Recent studies have highlighted the potential of Spiro[3.3]heptan-2-ylmethanol in the development of small-molecule inhibitors targeting enzymes involved in metabolic diseases and cancer. The spirocyclic scaffold has been shown to mimic natural substrates or transition states, thereby facilitating tight binding to enzymatic active sites. For example, derivatives of Spiro[3.3]heptan-2-ylmethanol have been investigated as inhibitors of kinases and proteases, which are key players in signal transduction and cell proliferation.

The pharmacological evaluation of Spiro[3.3]heptan-2-ylmethanol and its derivatives has revealed promising results in preclinical models. These studies have demonstrated that modifications to the spirocycle can significantly alter biological activity, leading to compounds with improved potency, selectivity, and pharmacokinetic profiles. The ability to fine-tune these properties through structural optimization underscores the importance of Spiro[3.3]heptan-2-ylmethanol as a pharmacophore in drug discovery.

From a material science perspective, Spiro[3.3]heptan-2-ylmethanol has also been explored for its potential applications in organic electronics and polymer chemistry. The rigid spirocore can contribute to enhanced thermal stability and electronic properties in materials used for light-emitting diodes (LEDs) and organic photovoltaics (OPVs). Researchers have investigated incorporating Spiro[3.3]heptan-2-ylmethanol into polymer backbones to improve charge transport properties and device performance.

The synthesis of Spiro[3.3]heptan-2-ylmethanol typically involves multi-step organic transformations starting from readily available precursors. Common synthetic routes include cyclization reactions followed by functional group interconversions to introduce the desired substituents at specific positions on the spirocycle. Advances in synthetic methodology have enabled more efficient and scalable production processes for this compound, making it more accessible for research applications.

In conclusion, Spiro[3.3]heptan-2-ylmethanol (CAS No. 4483-67-4) represents a structurally intriguing compound with broad applications across multiple scientific disciplines. Its unique spirocyclic framework offers opportunities for innovation in pharmaceuticals, materials science, and beyond. As research continues to uncover new synthetic strategies and biological functions associated with this molecule, its significance is expected to grow further.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)